Syok Clinical

download Syok Clinical

of 37

Transcript of Syok Clinical

  • 8/11/2019 Syok Clinical

    1/37

    Syokdan

    Tatalaksana terapi cairanRahardjo.

    s

  • 8/11/2019 Syok Clinical

    2/37

  • 8/11/2019 Syok Clinical

    3/37

    Klasifikasi :

    1. Shock Hypovolemik : Shock o.k : Penurunan volume intravaskuler, misal : perdarahan, dehidrasi

    2. Shock Kardiogenik : Shock o.k : Kegagalan pompa jantung, abnormalitas katub ataukah arritmia

    3. Shock Obstruktif : Shock o.k : Hambatan aliran darah yg kembali kejantung ( venous return ), misal :

    Tamponade jantung, konstriktif perikarditis, tension pneumothoraks

    4. Shock Distributif : Shock o.k : Gangguan vasomotor mengakibatkan turunnya SVR diikuti Curah Jantung yang

    tidak adekwat misal : Septic, Spinal, Nerogenic shock.

  • 8/11/2019 Syok Clinical

    4/37

    TandaTanda Shock

    1. Takikardia

    2. Akral dingin

    3. Kesadaran

    4. Takipnea

    5. Tensi

    shock !

  • 8/11/2019 Syok Clinical

    5/37

  • 8/11/2019 Syok Clinical

    6/37

    KLASIFIKASISYOKHEMORAGIK

    Kompensasi Ringan Sedang Berat

    Hilangdarah(ml)

    Denyutnadi

    (bpm)

    Tekanan darah

    Pengisian kapiler

    Pernafasan

    Urine(ml/h)

    Statusmental

    100Ortostatik

    Mungkin

    terlambat

    Peningkatan

    ringan

    2030

    Agitasi

    15002000

    >120Sangatturun

    Sering

    terlambat

    Takipnea

    sedang

    520

    Konfusi

    >2000

    >140Tidakterukur

    Selalu

    terlambat

    Takipneunyata,

    GagalNafas

    Anuria

    Letargi,

    tidaksadar

    Diagnosis

  • 8/11/2019 Syok Clinical

    7/37

    GAMBARAN

    KLINIK

    SYOK

    HEMORHAGISISTIM SYOKDINI SYOKLANJUT

    SARAFPUSAT PERUBAHAN

    STATUS

    MENTALPERUBAHAN

    KESADARAN

    KARDIAL TAKIKARDI

    HIPOTENSIORTOSTATIK

    HIPOTENSI

    ARITHMIA

    GAGAL JANTUNGRENAL OLIGOURI ANURI

    RESPIRASI TAKIPNOE TAKIPNOE,GAGALNAFAS

    HEPATIK GANGGUAN FUNGSI

    HEPAR

    GASTROINTESTINAL PERDARAHANMUKOSA

    HEMATOLOGI ANEMIA KOAGULOPATI

    METABOLIK

    ASIDOSISHIPOKALEMIA

    HIPOMAGNESEMIADiagnosis

  • 8/11/2019 Syok Clinical

    8/37Penanganan

    TatalaksanaSyok:

    Penanganan

    Syok

    :

    Tatalaksana

    terhadap

    Underlying

    injury

    or

    Disease

    Mengembalikan

    Perfusi

    Jaringan.

    Segera

    memberi

    /

    mengganti

    Volume

    Adekuat

    Ventilation

    &

    Oxygenation

    Adekuat

  • 8/11/2019 Syok Clinical

    9/37Penanganan

    Penangananterhadap Underlyinginjuryordisease

    TatalaksanaSyok:

  • 8/11/2019 Syok Clinical

    10/37

    ENHANCEMENTMICROCIRCULATIONBLOODFLOW

    Arterioles

    and

    arterial

    partofcapillaries

    Venules

    and

    venouspart

    of

    capillaries

    MengembalikanPerfusi

    Jaringan

    Penanganan

    TatalaksanaSyok:

  • 8/11/2019 Syok Clinical

    11/37

  • 8/11/2019 Syok Clinical

    12/37

    PENTING !l VOLUME INTRAVASKULAR

    l O2TRANSPORT

    (ERITROSIT

    )

    JUMLAHOKSIGENYANGTERSEDIAUNTUKJARINGAN:

    DO2=COX(SAT.O2XHbX1.39+PO2X0.003)

    = 5 l/m X 20 l/mO2/100ml

    = 1literO2/m

    KEBUTUHAN=25%=250mlO2/m

  • 8/11/2019 Syok Clinical

    13/37

    OxygenDelivery=

    COxCaO2(HbxSpO2x1,39+0,003xPaO2)

    O2content,O2extractingRatio,O2Consumption

    DeterminanuntukTissueoxygenation

    Komponen:CardiacOutput,Hb,

    SpO2arterial&venousblood

  • 8/11/2019 Syok Clinical

    14/37

    AdequateVentilationandOxygenation

    TatalaksanaSyok:

  • 8/11/2019 Syok Clinical

    15/37

    End Point of Resuscitation Therapy :

    BasicClinicalSign: PatientResponses

    HR

    >

    BPEvaluasithdPerfusi:

    UOP(UrineOutPut)

    CRT(CirculationPeripheral),

    LOC(Level

    of

    Consciousness

    )

    Produksi Urin/jam

    Tidak adekwatnya UOPberarti

    Tidak adekwatnya resusitasi

  • 8/11/2019 Syok Clinical

    16/37

    Advancedmethodsinclude

    Metabolik

    Serumlactate

    pCO2

    Base

    deficit Mixedvenoussaturations

    CVP : Preload.

    AdvancedEvaluation

    :

    CO,CI,LAP,PAOP,LVSVWI

    End Point of Resuscitation Therapy :

  • 8/11/2019 Syok Clinical

    17/37

    KontroversialPoin

    PeningkatanBPmeningkatkanresikoperdarahanpadakasus

    perdarahan.

    PemberianCairandanDarahakanmenurunkancoagulosi

    MacamCairan:

    Fluidvs.

    non

    fluid

    (vasopressors,

    etc.)

    Bloodvs.nonbloodfluid

    Wholebloodvs.bloodcomponents

    Crystalloidsvs.

    colloids

    vs.

    hypertonic

    saline

    Albuminvs.syntheticcolloids

  • 8/11/2019 Syok Clinical

    18/37

  • 8/11/2019 Syok Clinical

    19/37

    KONSEPBARU

    PERMISSIVEHYPOTENSION

    Pasientetapsadar

    Naditeraba

    SBP90mmHg

    MAP5060mmHg

    SaO2>92%

  • 8/11/2019 Syok Clinical

    20/37

    TERAPI

    CAIRAN

    PADA

    SYOK

    HEMORRHAGITujuanResusitasiCairan;

    MenujuNormovolumi

    dan

    HD

    stabil.

    MemeliharaadekuatColloidOncoticPressure

    Memeliharakeseimbangan

    dan

    komposisi

    KompartemenCairanTubuh.

  • 8/11/2019 Syok Clinical

    21/37

    RL

    RANaCl0.9%

    NaCl3%

    Albumin

    PlasmaDextran

    Gelatin

    HES

    COLLOIDCRYSTALLOID

    B

    L

    O

    O

    D

  • 8/11/2019 Syok Clinical

    22/37

    Body Fluid CompartmentsTotal body water = 60 % of body weight (BW)

    2/3

    Intracellular water= 40 % of BW

    1/3

    Extracellularwater

    = 20 % of BW

    Plasma (5 % of BW)

    Extracellularwater

    = 20 % of BW

  • 8/11/2019 Syok Clinical

    23/37

    increases ICF > ECFincreases ICF > ECF

    ICF ISF PlasmaICF ISF Plasma

    Replace Normalloss (IWL + urine)

    Replace Normalloss (IWL + urine)

    Hypotonic infusionHypotonic infusion 5% dextrose 5% dextrose

    85 ml85 ml255 ml255 ml660 ml660 ml

  • 8/11/2019 Syok Clinical

    24/37

    increases ECFincreases ECF

    ICF ISF PlasmaICF ISF Plasma

    Replace acute/abnormalloss

    Replace acute/abnormalloss

    Infus IsotonicInfus Isotonic

    800 ml 200 ml

    Ringers acetate

    Ringers lactate Normal saline

    Ringers acetate

    Ringers lactate Normal saline

  • 8/11/2019 Syok Clinical

    25/37

    KRISTALOID

    Keuntungan

    Komposisi elektrolit seimbang

    Tidak ada resiko alergi

    Tidak mempengaruhi hemostasis

    Mengakibatkan terjadinya diuresis Murah

  • 8/11/2019 Syok Clinical

    26/37

    Kerugian

    Perlu 3-4 x jumlah perdarahan

    Bisa mengakibatkan udem Mengakibatkan TOP berkurang.

    Hypothermia

    Lama kerja + 90 menit

    NaCl 0.9% : asidosis hiperchloremia

    KRISTALOID

  • 8/11/2019 Syok Clinical

    27/37

    0

    50

    100

    150

    200

    250

    D5WLactatedRingers

    Albumin5 %

    Volume(ml)

    Prough, Anesthesiology Clinics of North America (1996)

    Administration of 250 ml of fluid

    ICV

    ISV

    PV

  • 8/11/2019 Syok Clinical

    28/37

  • 8/11/2019 Syok Clinical

    29/37

  • 8/11/2019 Syok Clinical

    30/37

    KOLOID

    KEUNTUNGAN

    Tetapberada

    dalam

    volume

    intravaskular

    Kebutuhansamadenganjumlahdarahyang

    hilang

    MeningkatkanTOP

    Resikoudemminimal

    Meningkatkanaliran

    darah

    microvaskular

  • 8/11/2019 Syok Clinical

    31/37

    KERUGIAN

    Kelebihan beban cairan

    Mengganggu hemostasis

    Mempengaruhi fungsi ginjal

    Reaksi anafilaktoid

    Mahal

    KOLOID

  • 8/11/2019 Syok Clinical

    32/37

    16 hr

    16 hr

    17 day

    10 hr

    6 hr

    12 hr

    0.7 1.3

    4.0 5.0

    1.0 1.3

    1.5

    1.0 1.5

    0.8

    20 mm Hg

    70 Mm Hg

    30 Mm Hg

    40 Mm Hg

    40 Mm Hg

    40 Mm Hg

    69.000

    69.000

    69.000

    120.000

    26.000

    41.000

    5 % ALBUMIN

    25 % ALBUMIN

    6 % HETASTARCH

    10 % PENTASTARCH

    10 % DEXTRAN-40

    6 % DEXTRAN-70

    SERUM

    HALF-LIFE

    PLASMA

    VOLUME

    EXPANSION***

    ONCOTIC

    PRESSURE**

    AVERAGE

    MOLECULAR

    WEIGHT * (DALTONS)FLUID

    CHARACTERISTICS OF INTRAVENOUS

    COLLOID FLUIDS

  • 8/11/2019 Syok Clinical

    33/37

  • 8/11/2019 Syok Clinical

    34/37

    http://content.nejm.org/http://content.nejm.org/content/vol345/issue19/images/large/03f2.jpeg
  • 8/11/2019 Syok Clinical

    35/37

    Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock

    CVP

    denotes

    central

    venous

    pressure,

    MAP

    mean

    arterial

    pressure,

    and

    ScvO2centralvenousoxygensaturation

    Volume 345:1368-1377 November 8, 2001 Number 19

    http://content.nejm.org/http://content.nejm.org/content/vol345/issue19/images/large/03f2.jpeg
  • 8/11/2019 Syok Clinical

    36/37

    TREATMENT CONCEPT OF SHOCK

    ENHANCING PERFUSION / OXYGEN DELIVERY

    Oxygen delivery/DO2 = HR X SV X HbXSp02X1.39 + 0.03 X PaO2

    Cardiacoutput

    Arterial O2content

    FluidsTransfuse Partially

    dependent onFIO2 and

    pulmonary

    status

    Inotropes :Dopamin

    Dobutamin

    Norepinephrin

    Epinephrin

    DO2 = CO x CaO2

    ScvO2

  • 8/11/2019 Syok Clinical

    37/37